- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
7
7 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.7b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.75
7D
-4.0%
1Y
-28.4%
Tong Ren Tang Technologies
Market Cap: HK$4.5b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.47
7D
-3.6%
1Y
-35.3%
Essex Bio-Technology
Market Cap: HK$1.4b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.51
7D
-11.6%
1Y
-51.5%
China Shineway Pharmaceutical Group
Market Cap: HK$6.2b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.23
7D
-2.0%
1Y
-0.4%
Pak Fah Yeow International
Market Cap: HK$716.8m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.30
7D
-3.4%
1Y
-6.1%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.00
7D
0%
1Y
-26.5%
Jacobson Pharma
Market Cap: HK$2.2b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.08
7D
1.9%
1Y
-35.3%